Core Laboratories Inc. (CLB)
NYSE: CLB · Real-Time Price · USD
12.45
+0.06 (0.48%)
At close: Aug 14, 2026, 4:00 PM EDT
12.46
+0.01 (0.08%)
After-hours: Aug 14, 2026, 7:34 PM EDT
Core Laboratories Stock Forecast
Stock Price Forecast
According to 3 analysts polled by S&P Global, Core Laboratories stock has a consensus rating of "Buy" and an average price target of $15.17. The average 1-year stock price forecast is 21.85% higher than the current stock price, while the lowest is $11 (-11.65%) and the highest is $21 (+68.67%).
Price Target: $15.17 (+21.85%)
Analyst Consensus: Buy
Price Target
Chart* Price targets were last updated on Jul 15, 2026.
Analyst Ratings
The average analyst rating for Core Laboratories stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | May '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 1 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 1 | 1 | 1 | 1 | 1 | 0 |
| Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Bank of America Securities | Bank of America Securities | Sell Reiterates $12 → $11 | Sell | Reiterates | $12 → $11 | -11.65% | Jul 15, 2026 |
Financial Forecast
Revenue This Year
510.10M
from 526.52M
Decreased by -3.12%
Revenue Next Year
534.93M
from 510.10M
Increased by 4.87%
EPS This Year
0.45
from 0.75
Decreased by -40.00%
EPS Next Year
0.70
from 0.45
Increased by 54.82%
EPS and Forward PE are based on non-GAAP adjusted numbers.